参考文献/References:
[1] FIGUEIRA J,KHAN J,NUNES S,SIVAPRASAD S,ROSA A,de ABREU JF,et al.Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema[J].Br J Ophthalmol,2009,93(10):1341-1344.
[2] FRIBERG TR,MUSCH DC,LIM JI,MORSE L,FREEMAN W,SINCLAIR S.Prophylactic treatment of age-related macular degeneration report number 1:810-nanometer laser to eyes with drusen.Unilaterally eligible patients[J].Ophthalmology,2006,113(4):621-622.
[3] PARODI MB,SPASSE S,IACONO P,STEFANO G,CANZIANI T,RAVALICO G.Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser[J].Ophthalmology,2006,113(12):2237-2242.
[4] INAGAKI K,OHKOSHI K,OHDE S,DESHPANDE GA,EBIHARA N,MURAKAMI A.Comparative efficacy of pure yellow (577-nm) and 810-nm subthreshold micropulse laser photocoagulation combined with yellow (561-577-nm) direct photocoagulation for diabetic macular edema[J].Jpn J Ophthalmol,2015,59(1):21-28.
[5] VALLEJO-GARCIA JL,ASENCIO-DURAN M,PASTORA-SALVADOR N,VINCIGUERRA P,ROMANO MR.Role of inflammation in endophthalmitis[J].Mediators Inflamm,2012,2012:196094.
[6] WILLERMAIN F,ROSENBAUM JT,BODAGHI B,ROSENZWEIG HL,CHILDERS S,BEHREND T,et al.Interplay between innate and adaptive immunity in the development of non-infectious uveitis[J].Prog Retin Eye Res,2012,31(2):182-194.
[7] GUSTAVSSON C,AGARDH CD,AGARDH E.Profile of intraocular tumour necrosis factor-alpha and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy[J].Acta Ophthalmol,2013,91(5):445-452.
[8] WILSON AS,HOBBS BG,SHEN WY,SPEED TP,SCHMIDT U,BEGLEY CG,et al.Argon laser photocoagulation-induced modification of gene expression in the retina[J].Invest Ophthalmol Vis Sci,2003,44(4):1426-1434.
[9] STEFANSSON E.The therapeutic effects of retinal laser treatment and vitrectomy.A theory based on oxygen and vascular physiology[J].Acta Ophthalmol Scand,2001,79(5):435-440.
[10] PAGES G,POUYSSEGUR J.Transcriptional regulation of the vascular endothelial growth factor gene--a concert of activating factors[J].Cardiovasc Res,2005,65(3):564-573.
[11] OLSSON AK,DIMBERG A,KREUGER J,CLAESSON-WELSH L.VEGF receptor signalling-in control of vascular function[J].Nat Rev Mol Cell Biol,2006,7(5):359-371.
[12] LIMA ESR,SHEN J,HACKETT SF,KACHI S,AKIYAMA H,KIUCHI K,et al.The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization[J].FASEB J,2007,21(12):3219-3230.
[13] LIU XD,ZHOU XD,WANG Z,SHEN YM.Macular laser photocoagulation with or without intravitreal triamcinolone pretreatment for diabetic macular edema:a result from five randomized controlled trials[J].Int J Ophthalmol,2016,9(1):132-138.
[14] DORIN G.Subthreshold and micropulse diode laser photocoagulation[J].Semin Ophthalmol,2003,18(3):147-153.
[15] FLAXEL C,BRADLE J,ACOTT T,SAMPLES JR.Retinal pigment epithelium produces matrix metalloproteinases after laser treatment[J].Retina,2007,27(5):629-634.
[16] LAVINSKY D,SRAMEK C,WANG J,HUIE P,DALAL R,MANDEL Y,et al.Subvisible retinal laser therapy:titration algorithm and tissue response[J].Retina,2014,34(1):87-97.
[17] SZYMANSKA J,GORALCZYK K,KLAWE JJ,LUKOWICZ M,MICHALSKA M,GORALCZYK B,et al.Phototherapy with low-level laser influences the proliferation of endothelial cells and vascular endothelial growth factor and transforming growth factor-beta secretion[J].J Physiol Pharmacol,2013,64(3):387-391.
[18] MANDRIOTA SJ,MENOUD PA,PEPPER MS.Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells[J].J Biol Chem,1996,271(19):11500-11505.
[19] PARK MJ,KWAK HJ,LEE HC,YOO DH,PARK IC,KIM MS,et al.Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor[J].J Biol Chem,2007,282(42):30485-30496.
[20] PARK KS,KIM SS,KIM JC,KIM HC,IM YS,AHN CW,et al.Serum and tear levels of nerve growth factor in diabetic retinopathy patients[J].Am J Ophthalmol,2008,145(3):432-437.
[21] MYSONA BA,MATRAGOON S,STEPHENS M,MOHAMED IN,FAROOQ A,BARTASIS ML,et al.Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy[J].Biomed Res Int,2015,2015:571456.
[22] YAZDANI SO,GOLESTANEH AF,SHAFIEE A,HAFIZI M,OMRANI HA,SOLEIMANI M.Effects of low level laser therapy on proliferation and neurotrophic factor gene expression of human schwann cells in vitro[J].J Photochem Photobiol B,2012,107(1):9-13.
[23] KAUR J,ADYA R,TAN BK,CHEN J,RANDEVA HS.Identification of chemerin receptor (ChemR23) in human endothelial cells:chemerin-induced endothelial angiogenesis[J].Biochem Biophys Res Commun,2010,391(4):1762-1768.
[24] LI J,HU WC,SONG H,LIN JN,TANG X.Increased vitreous chemerin levels are associated with proliferative diabetic retinopathy[J].Ophthalmologica,2016,236(2):61-66.
[25] FRAMME C,BRINKMANN R,BIRNGRUBER R,ROIDER J.Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome:a pilot study[J].Br J Ophthalmol,2002,86(10):1099-1106.
[26] DORIN G.Evolution of retinal laser therapy:minimum intensity photocoagulation (MIP).Can the laser heal the retina without harming it[J]?Semin Ophthalmol,2004,19(1-2):62-68.